Koyfin Home > Directory > Health Care > Intercept Pharmaceuticals > Enterprise Value

Intercept Pharmaceuticals Enterprise Value Chart (ICPT)

Intercept Pharmaceuticals annual/quarterly Enterprise Value from 2012 to 2020.
  • Intercept Pharmaceuticals Enterprise Value for the quarter ending October 10, 2020 was $997m a -17.67% decrease of -176m year over year
  • Intercept Pharmaceuticals Enterprise Value for the last 12 months ending October 10, 2020 was $997m a -17.67% decrease of -176m year over year
  • Intercept Pharmaceuticals Annual Enterprise Value for 2020 was $997m a -2.98% decrease of -30m from 2019
  • Intercept Pharmaceuticals Annual Enterprise Value for 2020 was $1,026m a -6.15% decrease of -63m from 2019
  • Intercept Pharmaceuticals Annual Enterprise Value for 2020 was $1,089m a -7.64% decrease of -83m from 2019
Other Valuation Metrics:
  • Intercept Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $1,549m a -95.52% decrease of -1,479m year over year
  • Intercept Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 94.51 a 86.66% increase of 81.90 year over year
View Chart On Koyfin

Quarterly ICPT Enterprise Value Data

10/2020$997m
10/2020$1,026m
10/2020$1,089m
10/2020$1,173m
10/2020$1,168m
10/2020$1,152m
10/2020$1,179m
10/2020$1,135m
10/2020$1,235m
10/2020$1,267m

Annual ICPT Enterprise Value Data

2020$997m
2020$1,026m
2020$1,089m
2020$1,173m
2020$1,168m
2020$1,152m
2020$1,179m
2020$1,135m
2020$1,235m
2020$1,267m